[1] Williams S C. Circulating tumor cells[J]. Proc Natl Acad Sci U S A, 2013, 110(13): 4861.
[2] Balic M, Williams A, Lin H, et al. Circulating tumor cells: from bench to bedside[J]. Annual Review of Medicine, 2013, 64: 31-44.
[3] AlixPanabieres C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA[J]. Annual Review of Medicine, 2012, 63: 199-215.
[4] Pinzani P, Salvadori B, Simi L, et al. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with realtime reverse transcriptasepolymerase chain reaction results and feasibility of molecular analysis by laser microdissection[J]. Human Pathology, 2006, 37(6): 711-718.
[5] Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells[J]. Am J Pathol, 2000, 156(1): 57-63.[6] Alemar J, Schuur E R. Progress in using circulating tumor cell information to improve metastatic breast cancer therapy[J]. Journal of Oncology, 2013, 2013: 1-8.
[7] Rosenberg R, Gertler R, Friederichs J, et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood[J]. Cytometry, 2002, 49(4): 150-158.
[8] Mita A, Ricordi C, Messinger S, et al. Antiproinflammatory effects of iodixanol (optiprep)based density gradient purification on human islet preparations[J]. Cell Transplantation, 2010, 19(12): 1537-1546.
[9] Mita A, Ricordi C, Miki A, et al. Purification method using iodixanol (optiprep)based density gradient significantly reduces cytokine chemokine production from human islet preparations, leading to prolonged betacell survival during pretransplantation culture[J]. Transplantation Proceedings, 2009, 41(1): 314-315.
[10] Yu M, Bardia A, Wittner B S, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition[J]. Science, 2013, 339(6119): 580-584.
[11] Nole F, Munzone E, Zorzino L, et al. Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications[J]. Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO, 2008, 19(5): 891-897.
[1]郑罗凝,徐增辉,王真,等.基于OptiPrep的循环肿瘤细胞富集体系研究[J].浙江理工大学学报,2015,33-34(自科5):699.
ZHENG Luo ning,XU Zeng hui,WANG Zhen,et al.Study on OptiPrepbased Enrichment System of Circulating Tumor Cell[J].Journal of Zhejiang Sci-Tech University,2015,33-34(自科4):699.